Clinical implications of fetal magnetocardiography

Objectives To test the usefulness and reliability of fetal magnetocardiography as a diagnostic or screening tool, both for fetuses with arrhythmias as well as for fetuses with a congenital heart defect. Methods We describe 21 women with either a fetal arrhythmia or a congenital heart defect discover...

Full description

Saved in:
Bibliographic Details
Published inUltrasound in obstetrics & gynecology Vol. 20; no. 2; pp. 142 - 153
Main Authors Quartero, H. W. P., Stinstra, J. G., Golbach, E. G. M., Meijboom, E. J., Peters, M. J.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Science Ltd 01.08.2002
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objectives To test the usefulness and reliability of fetal magnetocardiography as a diagnostic or screening tool, both for fetuses with arrhythmias as well as for fetuses with a congenital heart defect. Methods We describe 21 women with either a fetal arrhythmia or a congenital heart defect discovered during prenatal evaluation by sonography. Four fetuses showed a complete atrioventricular block, two an atrial flutter, nine ventricular extrasystole, and one a complete irregular heart rate. Five fetuses were suspected to have a congenital heart defect. In all cases magnetocardiograms were recorded. Results Nine fetuses with extrasystole showed a range of premature atrial contractions, premature junctional beats or premature ventricular contractions. Two fetuses with atrial flutter showed typical flutter waves and four fetuses with complete atrioventricular block showed an uncoupling of P‐wave and QRS complex. One fetus showed a pattern suggestive of a bundle branch block. In three of four fetuses with confirmed congenital heart defects the magnetocardiogram showed abnormalities. Conclusion Fetal magnetocardiography allows an insight into the electrophysiological aspects of the fetal heart, is accurate in the classification of fetal arrhythmias, and shows potential as a tool in defining a population at risk for congenital heart defects.
Bibliography:Presented at The Fetal Medicine Foundation's meeting on Research and Developments in Fetal Medicine, London, August 30th–September 1st 2001.
ObjectType-Case Study-3
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-2
ISSN:0960-7692
1469-0705
DOI:10.1046/j.1469-0705.2002.00754.x